Results 31 to 40 of about 736 (146)

Ciprofol May Represent a Useful Sedative Option for Gastrointestinal Endoscopy. [PDF]

open access: yesDig Endosc
Digestive Endoscopy, Volume 38, Issue 5, May 2026.
Yamamura T, Nakamura M, Kawashima H.
europepmc   +2 more sources

Ciprofol: A Novel Alternative to Propofol in Clinical Intravenous Anesthesia?

open access: yesBioMed Research International, Volume 2023, Issue 1, 2023., 2023
Ciprofol is a novel compound that was independently developed in China. According to the Chinese product instructions approved by the China National Medical Products Administration and the information of official website, indications for ciprofol include sedation and anesthesia during the surgical/procedure of nontracheal intubation, induction and ...
Ming Lu   +4 more
wiley   +1 more source

Comparison and Clinical Value of Ciprofol and Propofol in Intraoperative Adverse Reactions, Operation, Resuscitation, and Satisfaction of Patients under Painless Gastroenteroscopy Anesthesia

open access: yesContrast Media &Molecular Imaging, Volume 2022, Issue 1, 2022., 2022
Objective. To investigate the comparison and clinical value of ciprofol and propofol for painless gastroenteroscopy anesthesia in terms of intraoperative adverse reactions, operation, resuscitation, and satisfaction of patients. Methods. A total of 96 patients who underwent painless gastroenteroscopy anesthesia in our hospital from June 2021 to January
Xingqu Chen   +5 more
wiley   +1 more source

Study on the effectiveness and safety of ciprofol in anesthesia in gynecological day surgery: a randomized double-blind controlled study

open access: yesBMC Anesthesiology, 2023
Backgroud ciprofol is a new type of intravenous anesthetic, which is a tautomer of propofol, with the characteristics of less injection pain, less respiratory depression and higher potency, but little clinical experience.
Yan Man   +3 more
doaj   +1 more source

A case report of ciprofol overdose during anesthesia/analgesia and literature review: clinical presentation, blood pressure, and management

open access: yesJournal of International Medical Research, 2022
Ciprofol is a novel intravenous anesthetic agent and a highly selective gamma-aminobutyric acid-A receptor agonist, similar to propofol. This is the first report about ciprofol overdose occurring during the maintenance phase of anesthesia for a surgical ...
Ai Wei   +5 more
doaj   +1 more source

Table1_Pharmacokinetics, pharmacodynamics, and safety of ciprofol emulsion in Chinese subjects with normal or impaired renal function.docx

open access: yes, 2023
Background: Ciprofol, a novel sedative–hypnotic drug, has been approved for its use in inducing and maintaining general anesthesia, as well as for providing sedation.Methods: In this phase I, single-center, parallel, controlled, open-label clinical trial,
Lei Qi (173882)   +8 more
core   +1 more source

Efficacy and safety of ciprofol-remifentanil versus propofol-remifentanil during fiberoptic bronchoscopy: A prospective, randomized, double-blind, non-inferiority trial

open access: yesFrontiers in Pharmacology, 2022
Objective: Ciprofol is a novel 2,6-disubstituted phenol derivative that has improved pharmacokinetic and pharmacodynamic properties compared with propofol.
Bin Wu   +5 more
doaj   +1 more source

Advantages of Ciprofol with Special Consideration of Pediatric Anesthesia. [PDF]

open access: yesChildren (Basel)
The search for an ideal anesthetic has always been a major goal in anesthesiology. In recent years, the introduction of ciprofol has marked a major breakthrough in the pharmacological field, following the introduction of dexmedetomidine.
Vittori A   +12 more
europepmc   +2 more sources

Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mechanical ventilation: a multi-center, open label, randomized, phase 2 trial

open access: yesChinese Medical Journal, 2022
. Background:. Ciprofol (HSK3486; Haisco Pharmaceutical Group Co., Ltd., Chengdu, China), developed as a novel 2,6-disubstituted phenol derivative showed similar tolerability and efficacy characteristics as propofol when applicated as continuous ...
Yongjun Liu   +11 more
doaj   +1 more source

Issue Information

open access: yes, 2023
Clinical and Translational Science, Volume 16, Issue 10, Page 1737-1740, October 2023.
wiley   +1 more source

Home - About - Disclaimer - Privacy